| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Pfizer |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
| Company: AstraZeneca/MedImmune |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Merck |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Tesaro |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Seattle Genetics |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: GlaxoSmithKline |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb/Celgene |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: McGraw Hill Publishing |
| Recipient: You |
| Please describe: UpToDate - Wolters Kluwer - Author of chapters |
| Recipient: You |
| Please describe: Elsevier - Editor of Book |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Pfizer |
| Recipient: You |
|
| Other Relationship |
| Company: MJH/PER |
| Recipient: You |
| Company: Curio/Vaniam Group |
| Recipient: You |
| Company: Medscape |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|